EVIAGENICS

About:

EVIAGENICS develops new products and improved manufacturing processes for the chemical and pharmaceutical industries.

Website: http://eviagenics.com

Top Investors: Karista, Emertec, CEA Investissement

Description:

EVIAGENICS is a biotechnology company generating new products and improved manufacturing processes for the chemical and pharmaceutical industry by applying its unique in vivo recombination technology. After the successful validation of the technology in several collaborations with industrial partners from red and white biotechnology EVIAGENICS will focus its activities on the development of a technology platform for the efficient recombination and expression of metabolic pathways in cells. These reprogrammed cells will be able to transform sugars from cheap renewable sources like feedstock into numerous new high value compounds.

Total Funding Amount:

1.3M EUR

Headquarters Location:

Paris, Ile-de-France, France

Founded Date:

2004-01-01

Founders:

Number of Employees:

11-50

Last Funding Date:

2011-01-24

IPO Status:

Private

Industries:

© 2025 bioDAO.ai